Listen To The Story
Marketplace

More patients who are terminally ill will potentially have access to experimental drugs under a measure passed by the House last night. President Donald Trump is expected to sign the so-called "right-to-try" bill. Forty states have already passed similar legislation. Currently, terminal patients not covered by those laws have only two options for getting unapproved drugs: They can enroll in clinical trials if they're eligible or apply for experimental treatment through the FDA's "expanded access" program. Proponents of the measure say the additional choice gives hope to patients who have exhausted other options. But the new law wouldn't necessarily guarantee access.

Click the audio player above to hear the full story. 

“I think the best compliment I can give is not to say how much your programs have taught me (a ton), but how much Marketplace has motivated me to go out and teach myself.” – Michael in Arlington, VA

As a nonprofit news organization, what matters to us is the same thing that matters to you: being a source for trustworthy, independent news that makes people smarter about business and the economy. So if Marketplace has helped you understand the economy better, make more informed financial decisions or just encouraged you to think differently, we’re asking you to give a little something back.

Become a Marketplace Investor today – in whatever amount is right for you – and keep public service journalism strong. We’re grateful for your support.

Follow Amy Scott at @amyreports